NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Depreciation in USD from Q1 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Depreciation history and growth rate from Q1 2019 to Q2 2025.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Depreciation for the quarter ending June 30, 2025 was $61K, a 6.06% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Depreciation for the twelve months ending June 30, 2025 was $239K, a 7.32% increase year-over-year.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation for 2024 was $224K, a 26.9% increase from 2023.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation for 2023 was $177K, a 83.7% increase from 2022.
  • NEUROONE MEDICAL TECHNOLOGIES Corp annual Depreciation for 2022 was $96.3K, a 64.8% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $239K $61K +$3.49K +6.06% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $236K $60.1K +$4.73K +8.56% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $231K $59.5K +$6.47K +12.2% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-12
Q3 2024 $224K $58.5K +$1.62K +2.84% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-17
Q2 2024 $223K $57.5K +$6.15K +12% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $217K $55.3K +$17K +44.3% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $200K $53.1K +$22.8K +75.1% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-12
Q3 2023 $177K $56.9K +$29.1K +104% Jul 1, 2023 Sep 30, 2023 10-K 2024-12-17
Q2 2023 $148K $51.4K +$25.5K +98.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $122K $38.3K +$15.4K +67% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $107K $30.3K +$10.7K +54.8% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 $96.3K $27.8K +$11.1K +65.9% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-15
Q2 2022 $85.2K $25.9K +$11.2K +75.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $74.1K $23K +$9.24K +67.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $64.9K $19.6K +$6.43K +48.8% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 $58.4K $16.8K +$8.6K +105% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-22
Q2 2021 $49.8K $14.8K +$7.48K +102% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $42.4K $13.7K +$8.23K +150% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $34.1K $13.2K +$8.84K +205% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 $25.3K $8.19K Jul 1, 2020 Sep 30, 2020 10-K/A 2022-05-31
Q2 2020 $7.3K +$6.6K +952% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $5.49K +$5.49K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $4.32K Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q2 2019 $694 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.